For instance, miR-16 inhibits cell proliferation by targeting IGF1R and the Raf1-MEK1/2-ERK1/2 pathway in osteosarcoma [20], and miR-802 promotes osteosarcoma cell proliferation by down-regulating the p27 cell-cycle inhibitor [21]. Here, MAP2K1 is linked to osteosarcoma.